Isoprenoid-phospholipid Conjugates As Potential Therapeutic Agents: Synthesis, Characterization and Antiproliferative Studies
Overview
Affiliations
The aim of this research was to extend application field of isoprenoid compounds by their introduction into phospholipid structure as the transport vehicle. The series of novel isoprenoid phospholipids were synthesized in high yields (24-97%), their structures were fully characterized and its anticancer activity was investigated in vitro towards several cell lines of different origin. Most of synthesized compounds showed a significantly higher antiproliferative effect on tested cell lines than free terpene acids. The most active phosphatidylcholine analogue, containing 2,3-dihydro-3-vinylfarnesoic acids instead of fatty acids in both sn-1 and sn-2 position, inhibits the proliferation of colon cancer cells at 13.6 μM.
Thiruchenthooran V, Switalska M, Maciejewska G, Palko-Labuz A, Bonilla-Vidal L, Wietrzyk J Int J Nanomedicine. 2024; 19:12695-12718.
PMID: 39619057 PMC: 11608545. DOI: 10.2147/IJN.S477512.
Czarnecka M, Switalska M, Wietrzyk J, Maciejewska G, Gliszczynska A RSC Adv. 2022; 8(62):35744-35752.
PMID: 35547935 PMC: 9088016. DOI: 10.1039/c8ra07002d.
Pruchnik H, Gliszczynska A, Wloch A Int J Mol Sci. 2021; 22(23).
PMID: 34884953 PMC: 8658227. DOI: 10.3390/ijms222313146.
Malodobra-Mazur M, Lewon D, Cierzniak A, Okulus M, Gliszczynska A Nutrients. 2021; 13(10).
PMID: 34684619 PMC: 8537072. DOI: 10.3390/nu13103619.
Palko-Labuz A, Gliszczynska A, Skonieczna M, Pola A, Wesolowska O, Sroda-Pomianek K Int J Mol Sci. 2021; 22(16).
PMID: 34445104 PMC: 8395125. DOI: 10.3390/ijms22168397.